You are invited to participate in a stakeholder call to discuss naloxone access on November 28 at 2:30pm ET. Speakers will include FDA Commissioner Dr. Robert Califf and Marta Sokolowska, FDA Deputy Director for Substance Use and Behavioral Health. Dr. Miriam Delphin-Rittmon, SAMHSA Assistant Secretary for Mental Health and Substance Use, will also participate on the call. Read more
top of page
Search
Recent Posts
See AllSAMHSA [2/02] - Recently, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced funding opportunities for grant programs aimed at expanding substance use disorder treatment
NIDA | Overdose deaths rose markedly between January to June 2018 and July to December 2021 among 10- to 44-year-old girls and women who were pregnant or pregnant within the previous 12 months. [...]
bottom of page